Immunocore Holdings Number Of Shares Shorted vs. Gross Profit
| IMCR Stock | USD 32.45 0.34 1.04% |
For Immunocore Holdings profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Immunocore Holdings to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Immunocore Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Immunocore Holdings's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Immunocore Holdings over time as well as its relative position and ranking within its peers.
Immunocore |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 8.22 | Earnings Share (0.95) | Revenue Per Share 5.942 | Quarterly Revenue Growth 0.237 | Return On Assets (0.05) |
The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immunocore Holdings Gross Profit vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Immunocore Holdings's current stock value. Our valuation model uses many indicators to compare Immunocore Holdings value to that of its competitors to determine the firm's financial worth. Immunocore Holdings is rated fifth overall in number of shares shorted category among its peers. It is rated second overall in gross profit category among its peers fabricating about 6.79 of Gross Profit per Number Of Shares Shorted. At this time, Immunocore Holdings' Gross Profit is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Immunocore Holdings by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Immunocore Gross Profit vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Immunocore Holdings |
| = | 7.97 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Immunocore Holdings |
| = | 54.11 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Immunocore Gross Profit Comparison
Immunocore Holdings is currently under evaluation in gross profit category among its peers.
Immunocore Holdings Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Immunocore Holdings, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Immunocore Holdings will eventually generate negative long term returns. The profitability progress is the general direction of Immunocore Holdings' change in net profit over the period of time. It can combine multiple indicators of Immunocore Holdings, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -36.3 M | -34.4 M | |
| Net Loss | -37.1 M | -39 M | |
| Income Tax Expense | -5.6 M | -5.9 M | |
| Net Interest Income | 4.5 M | 4.7 M | |
| Interest Income | 12.5 M | 13.1 M | |
| Operating Income | -59.6 M | -62.6 M | |
| Net Loss | -54.1 M | -56.8 M | |
| Income Before Tax | -60.9 M | -63.9 M | |
| Total Other Income Expense Net | -1.2 M | -1.2 M | |
| Net Loss | -55.3 M | -58.1 M | |
| Change To Netincome | 25.4 M | 26.7 M | |
| Net Loss | (1.13) | (1.19) | |
| Income Quality | (0.07) | (0.06) | |
| Net Income Per E B T | 0.91 | 0.70 |
Immunocore Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Immunocore Holdings. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Immunocore Holdings position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Immunocore Holdings' important profitability drivers and their relationship over time.
Use Immunocore Holdings in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immunocore Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will appreciate offsetting losses from the drop in the long position's value.Immunocore Holdings Pair Trading
Immunocore Holdings Pair Trading Analysis
The ability to find closely correlated positions to Immunocore Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immunocore Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immunocore Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immunocore Holdings to buy it.
The correlation of Immunocore Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunocore Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunocore Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immunocore Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Immunocore Holdings position
In addition to having Immunocore Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Funds Thematic Idea Now
Precious Metals Funds
Funds or Etfs that invest in entities that are involved in mining, processing or dealing of precious metals. The Precious Metals Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.